Elyssa Rubin, MD
Office and Contact Information
CHOC Children's Specialists
1201 W. La Veta Ave.
Orange, CA 92868
phone: (714) 509-8636
fax: (714) 509-8699
map & directions
- Oncology, CHOC Children's Specialists
- Co-director, Bone and Soft Tissue Tumor Program, CHOC Children's Hyundai Cancer Institute
- Assistant Professor of Pediatrics
University of California, Irvine, School of Medicine
Physician / Researcher BioElyssa Rubin, M.D. has joined the Oncology Division of CHOC Children's Specialists. Dr. Rubin is board certified in pediatrics and pediatric hematology/oncology. Dr. Rubin completed her medical school training at the Sackler School of Medicine, NY State/American Branch in Tel Aviv, Israel. She completed her pediatric internship and residency training at Kaiser Permanente Los Angeles Medical Center and her fellowship in pediatric hematology/oncology at Children's Hospital of Orange County. As a research fellow, her focus was on new therapeutic targets for osteosarcoma. She has special interests in sarcomas and the histiocytic disorders.
Pediatric Hematology and Oncology at Children's Hospital of Orange County, Orange,California
- Pediatric Internship and Residency
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
- Medical School
Sackler School of Medicine, NY State/American Branch, Tel Aviv, Israel
- Pediatric Hematology/Oncology
- Children’s Oncology Group (COG)
- Connective Tissue Oncology Society (CTOS)
- Histiocyte Association of America (HAA)
- American Society of Clinical Oncology (ASCO)
- American Society of Pediatric Hematology and Oncology (ASPHO)
- American Society for Blood and Marrow Transplantation (ASBMT)
- American Association for Cancer Research (AACR)
Buchbinder, D., Hsieh, L., Puthenveetil G., Soni A., Stites J., Huynh V., Kirov I., Neudorf S., Rubin E., Sender L., Torno L., Margolis D., Childs R., Moore T., Nugent D.
Successful Autologous cord blood transplantation in a child with acquired severe aplastic anemia. Pediatr Transplant, 2013 May;17(3):E104-7. Doi: 10.1111/petr.12068. Epub 2013 Mar 7.
McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH. The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Review of Anticancer Therapy. 11(8):1223-32 (2011). PMID 21916576
Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH. Wnt inhibitory factor 1decreases tumorigenesis and metastasis in osteosarcoma, Mol Cancer Ther. 2010 Mar:9(3):731-41. Epub 2010 Mar 2. PMID: 20197388